EV Nickel Inc. | WebDisclosure

Basculer en Français

8302	Companies
115129	Keywords
55450	Articles
62533	Press releases

Home
Companies
EV Nickel Inc.

BRIEF

published on 05/08/2024 at 07:35, 6 months 13 days ago

APONTIS PHARMA annonce un début positif pour son exercice 2024 avec une augmentation des revenus d'une pilule unique

Croissance Financière Industrie Pharmaceutique PHARMA APONTIS Accord Novartis Revenus D'une Seule Pilule
PRESS RELEASE

published on 05/08/2024 at 07:30, 6 months 13 days ago

APONTIS PHARMA starts financial year 2024 with growth in revenue of Single Pill combinations and positive net result – forecast for full-year 2024 confirmed
APONTIS PHARMA reports growth in revenue of Single Pill combinations and positive net result in Q1 2024, confirming forecast for full-year 2024. Improved EBITDA and new sales model aims to increase revenue further

Revenue Growth Forecast APONTIS PHARMA Single Pill Combinations Q1 2024
BRIEF

published on 04/16/2024 at 13:05, 7 months 5 days ago

EV Nickel Inc. Launches Comprehensive 2024 Exploration Program

Sustainable Mining Clean Energy Nickel Exploration Canadian Mining Mineral Finance
BRIEF

published on 04/16/2024 at 13:05, 7 months 5 days ago

EV Nickel Inc. lance un programme d'exploration complet pour 2024

Énergie Propre Exploitation Minière Durable Exploitation Minière Canadienne Exploration Du Nickel Financement Minier
PRESS RELEASE

published on 04/16/2024 at 13:00, 7 months 5 days ago

EV Nickel Announces Fully Funded Exploration Program
EV Nickel Inc. announces its 2024 exploration program focusing on its significant Nickel deposits in Timmins, Ontario, following a $5.1M financing. The program includes geophysical surveys, metallurgical test work, and diamond drilling

Diamond Drilling 2024 Exploration Program EV Nickel Inc. Nickel Deposits Timmins Ontario
PRESS RELEASE

published on 04/15/2024 at 14:01, 7 months 6 days ago

Original-Research: Apontis Pharma AG (von Montega AG): Kaufen
Montega AG stuft Apontis Pharma AG hoch und aktualisiert das Kursziel auf 16,50 EUR aufgrund neuer Vertriebsstrategie und Kooperation mit Novartis. Analyst Tim Kruse empfiehlt Kauf

Montega AG APONTIS PHARMA AG Kursziel 16,50 EUR Vertriebsstrategie Kooperation Novartis
BRIEF

published on 04/05/2024 at 10:22, 7 months 16 days ago

APONTIS PHARMA Secures Five-Year Distribution and Marketing Deal with Novartis for Asthma Medications

Pharmaceutical Industry Financial Forecast APONTIS PHARMA Asthma Medications Novartis
BRIEF

published on 04/05/2024 at 10:22, 7 months 16 days ago

APONTIS PHARMA conclut un accord de distribution et de commercialisation de cinq ans avec Novartis pour des médicaments contre l'asthme

Prévisions Financières Industrie Pharmaceutique PHARMA APONTIS Médicaments Contre L'asthme Novartis
PRESS RELEASE

published on 04/05/2024 at 10:17, 7 months 16 days ago

APONTIS PHARMA enters five-year distribution and marketing agreement with Novartis for two asthma medications and raises forecast
APONTIS PHARMA partners with Novartis for asthma medications distribution and marketing, raising forecast for 2024 financial year

Distribution Agreement APONTIS PHARMA Asthma Medications Novartis Forecast Increase
BRIEF

published on 04/05/2024 at 10:15, 7 months 16 days ago

APONTIS PHARMA AG Enhances Forecast Following Agreement with Novartis

APONTIS PHARMA AG Financial Growth Forecast Upgrade Novartis Agreement Asthma Medications

Accesswire

Published on 11/22/2024 at 00:00, 6 hours 43 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 8 hours 38 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 8 hours 53 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 10 hours 28 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 10 hours 33 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 19:01, 11 hours 42 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/21/2024 at 18:36, 12 hours 7 minutes ago

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Published on 11/21/2024 at 17:58, 12 hours 44 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/21/2024 at 17:51, 12 hours 51 minutes ago

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Published on 11/21/2024 at 17:51, 12 hours 51 minutes ago

LIGHTON annonce le vif succès de son introduction en Bourse sur Euronext Growth Paris.

Les Echos

Published on 11/21/2024 at 06:58, 23 hours 45 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 23 hours 45 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 23 hours 45 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 1 day 10 hours ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day 11 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE